JP2009515827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009515827A5 JP2009515827A5 JP2008536134A JP2008536134A JP2009515827A5 JP 2009515827 A5 JP2009515827 A5 JP 2009515827A5 JP 2008536134 A JP2008536134 A JP 2008536134A JP 2008536134 A JP2008536134 A JP 2008536134A JP 2009515827 A5 JP2009515827 A5 JP 2009515827A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- nucleic acid
- ramp
- amino acid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0521139.6A GB0521139D0 (en) | 2005-10-18 | 2005-10-18 | Therapeutic agent |
| PCT/GB2006/050338 WO2007045927A2 (en) | 2005-10-18 | 2006-10-18 | Therapeutic agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012190219A Division JP2012246309A (ja) | 2005-10-18 | 2012-08-30 | 治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009515827A JP2009515827A (ja) | 2009-04-16 |
| JP2009515827A5 true JP2009515827A5 (https=) | 2011-06-02 |
Family
ID=35451928
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008536134A Pending JP2009515827A (ja) | 2005-10-18 | 2006-10-18 | 治療薬 |
| JP2012190219A Pending JP2012246309A (ja) | 2005-10-18 | 2012-08-30 | 治療薬 |
| JP2014193911A Pending JP2015003920A (ja) | 2005-10-18 | 2014-09-24 | 治療薬 |
| JP2015133603A Pending JP2015178534A (ja) | 2005-10-18 | 2015-07-02 | 治療薬 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012190219A Pending JP2012246309A (ja) | 2005-10-18 | 2012-08-30 | 治療薬 |
| JP2014193911A Pending JP2015003920A (ja) | 2005-10-18 | 2014-09-24 | 治療薬 |
| JP2015133603A Pending JP2015178534A (ja) | 2005-10-18 | 2015-07-02 | 治療薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20080279857A1 (https=) |
| EP (2) | EP1945670A2 (https=) |
| JP (4) | JP2009515827A (https=) |
| KR (1) | KR20080059449A (https=) |
| CN (2) | CN101341171A (https=) |
| AU (1) | AU2006305654B2 (https=) |
| CA (1) | CA2624931A1 (https=) |
| GB (1) | GB0521139D0 (https=) |
| RU (1) | RU2008119096A (https=) |
| WO (1) | WO2007045927A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| GB0521139D0 (en) | 2005-10-18 | 2005-11-23 | Univ Sheffield | Therapeutic agent |
| GB0708002D0 (en) | 2007-04-25 | 2007-06-06 | Univ Sheffield | Antibodies |
| CA2693310C (en) | 2007-08-02 | 2018-11-27 | Arresto Biosciences, Inc. | Lox and loxl2 inhibitors, antibodies and uses thereof |
| WO2009069546A1 (ja) | 2007-11-26 | 2009-06-04 | Japan Science And Technology Agency | 代謝症候群の治療もしくは予防剤、検査方法、検査薬、及び代謝症候群の治療薬の候補化合物のスクリーニング方法 |
| FR2934597B1 (fr) * | 2008-07-31 | 2013-04-19 | Univ Aix Marseille Ii | Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament. |
| JO3382B1 (ar) * | 2008-12-23 | 2019-03-13 | Amgen Inc | أجسام مضادة ترتبط مع مستقبل cgrp بشري |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| EP2467396A4 (en) | 2009-08-21 | 2012-12-26 | Gilead Biologics Inc | CATALYTIC DOMAINS FROM LYSYL OXIDASE AND LOXL2 |
| US8680246B2 (en) | 2010-02-04 | 2014-03-25 | Gilead Biologics, Inc. | Antibodies that bind to lysyl oxidase-like 2 (LOXL2) |
| FR2964103B1 (fr) | 2010-08-30 | 2018-11-23 | Universite D'aix-Marseille | Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament |
| JP5806859B2 (ja) * | 2011-06-08 | 2015-11-10 | ポーラ化成工業株式会社 | スクリーニング方法 |
| EP2589963A1 (en) | 2011-11-04 | 2013-05-08 | Université de Provence (Aix-Marseille 1) | Diagnostic and treatment of an androgen-independent prostate cancer |
| WO2016044224A1 (en) | 2014-09-15 | 2016-03-24 | Amgen Inc. | Bi-specific anti-cgrp receptor/pac1 receptor antigen binding proteins and uses thereof |
| JP6508670B2 (ja) * | 2014-12-26 | 2019-05-08 | 国立大学法人広島大学 | 軟骨変性抑制剤 |
| TWI799849B (zh) | 2015-04-24 | 2023-04-21 | 美商安美基公司 | 治療或預防偏頭痛之方法 |
| CN105420247B (zh) * | 2015-12-09 | 2018-09-07 | 浙江大学 | 水稻不定根控制基因crlr1的应用 |
| CN110290799A (zh) * | 2016-12-13 | 2019-09-27 | 防御素治疗学公司 | 用于治疗肺部炎性病症的方法 |
| JP7202011B2 (ja) * | 2017-09-13 | 2023-01-11 | キッズウェル・バイオ株式会社 | 抗ｒａｍｐ２抗体 |
| AU2019246983B2 (en) | 2018-04-02 | 2025-12-18 | Amgen Inc. | Erenumab compositions and uses thereof |
| JP2022512860A (ja) * | 2018-11-06 | 2022-02-07 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 白血病幹細胞を根絶することによる急性骨髄性白血病の治療のための方法および医薬組成物 |
| GB202303531D0 (en) * | 2023-03-10 | 2023-04-26 | Fusion Antibodies Plc | Antibodies and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3045153A1 (de) | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| EP1690934A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| EP0786469B1 (en) | 1990-06-11 | 2006-03-01 | Gilead Sciences, Inc. | Methods of use of nucleic acid ligands |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| EP0585287B1 (en) | 1990-07-10 | 1999-10-13 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
| AU701578B2 (en) | 1992-08-21 | 1999-02-04 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| KR100272659B1 (ko) | 1997-06-28 | 2000-12-01 | 김영환 | 반도체 소자의 금속배선 선폭 측정방법 |
| US20030055231A1 (en) * | 1998-10-28 | 2003-03-20 | Jian Ni | 12 human secreted proteins |
| EP1283881A2 (de) | 2000-05-26 | 2003-02-19 | Noxxon Pharma AG | Immobilisierte nukleinsäuren und verwendungen davon |
| WO2004050834A2 (en) * | 2002-11-27 | 2004-06-17 | Genpath Pharmaceuticals, Incorporated | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| GB0521139D0 (en) | 2005-10-18 | 2005-11-23 | Univ Sheffield | Therapeutic agent |
| GB0708002D0 (en) * | 2007-04-25 | 2007-06-06 | Univ Sheffield | Antibodies |
-
2005
- 2005-10-18 GB GBGB0521139.6A patent/GB0521139D0/en not_active Ceased
-
2006
- 2006-10-18 EP EP06794995A patent/EP1945670A2/en not_active Withdrawn
- 2006-10-18 RU RU2008119096/13A patent/RU2008119096A/ru not_active Application Discontinuation
- 2006-10-18 CN CNA2006800477847A patent/CN101341171A/zh active Pending
- 2006-10-18 EP EP11162714A patent/EP2402372A3/en not_active Withdrawn
- 2006-10-18 KR KR1020087011686A patent/KR20080059449A/ko not_active Withdrawn
- 2006-10-18 WO PCT/GB2006/050338 patent/WO2007045927A2/en not_active Ceased
- 2006-10-18 CA CA002624931A patent/CA2624931A1/en not_active Abandoned
- 2006-10-18 US US12/090,635 patent/US20080279857A1/en not_active Abandoned
- 2006-10-18 CN CN201510206436.0A patent/CN105037551A/zh active Pending
- 2006-10-18 JP JP2008536134A patent/JP2009515827A/ja active Pending
- 2006-10-18 AU AU2006305654A patent/AU2006305654B2/en not_active Ceased
-
2010
- 2010-08-03 US US12/849,536 patent/US8895005B2/en not_active Expired - Fee Related
-
2012
- 2012-08-30 JP JP2012190219A patent/JP2012246309A/ja active Pending
-
2014
- 2014-09-24 JP JP2014193911A patent/JP2015003920A/ja active Pending
- 2014-10-09 US US14/511,099 patent/US9556268B2/en not_active Expired - Fee Related
-
2015
- 2015-07-02 JP JP2015133603A patent/JP2015178534A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9556268B2 (en) | Therapeutic agent | |
| JP2009515827A5 (https=) | ||
| CN107847595B (zh) | 特异性针对过度磷酸化τ蛋白的抗体及其使用方法 | |
| CN107098970B (zh) | 结合细胞内prl-1多肽或prl-3多肽的抗体 | |
| CN110267985B (zh) | 用于治疗眼科疾病的特异性针对过度磷酸化τ蛋白的抗体 | |
| KR20180064541A (ko) | 항-il-2 항체 및 조성물 및 이의 용도 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| RU2741802C2 (ru) | АНТИТЕЛО К Myl9 | |
| CN112243443A (zh) | 抗trop-2抗体、其抗原结合片段及其医药用途 | |
| CN115298216A (zh) | 抗体或其抗原结合片段、其制备方法及医药用途 | |
| KR20100034720A (ko) | 피에이유에프(ｐａｕｆ) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법 | |
| CN110606892B (zh) | 一种高亲和力高生物活性的lag-3抗体及其应用 | |
| JP2021535078A (ja) | 骨の疾患の治療に用いるためのトランスフェリン受容体２のアンタゴニスト及びアゴニスト | |
| CN111205370A (zh) | 抗ptn抗体在抑制白血病干细胞以及治疗慢性粒细胞白血病中的应用 | |
| JP7643727B2 (ja) | 抗－ｆｇｆ１９抗体 | |
| JP7564882B2 (ja) | Ａｒｅｇに対する抗体及びその用途 | |
| HK40049006B (en) | Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof | |
| HK40049006A (en) | Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof | |
| JP2026507922A (ja) | 制御性ｔ細胞表面抗原のエピトープおよびこれに特異的に結合する抗体 | |
| HK40036076B (en) | Anti-trop-2 antibody, antigen binding fragment thereof and medical use thereof | |
| HK40036076A (en) | Anti-trop-2 antibody, antigen binding fragment thereof and medical use thereof | |
| HK40005045B (zh) | 用於治疗ror1癌症并抑制转移的抗体和疫苗 | |
| JP2003310276A (ja) | １２１４位チロシンがリン酸化したＫＤＲ／Ｆｌｋ−１に対する情報伝達分子の結合を阻害する物質およびその利用方法 |